ImmunoCellular Therapeutics To Present At 2nd World Cancer Vaccines Summit
6/23/2011

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular" or the "Company")(OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced today that Manish Singh Ph.D., the Company's President and CEO, will present at the 2nd World Cancer Vaccines Summit at the Radisson Hotel in Boston, MA on Thursday, June 23rd at 2:00 p.m...

Ligand To Advance Clinical Development Of Captisol-Enabled(R), Propylene Glycol-Free Melphalan For Multiple Myeloma
6/23/2011

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that it has made the strategic decision to internally advance development of its Captisol-enabled melphalan program with the current goal to file a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) by mid-2013 if the development is successful...

ALICE's Brilliance To Spark Breakthrough In Cell Biology And Cancer Research At Daresbury
6/23/2011

Unique research carried out at the Science and Technology Facilities Council's (STFC) Daresbury Laboratory in Cheshire is set to trigger a new era in research into cancer diagnosis and our understanding of how living things function...

More Rural Australians Urged To Take Home Bowel Cancer Test
6/23/2011

Rural doctors are urging more rural Australians to undertake a painless, at-home bowel cancer test to help reduce deaths by cancer...

Women With Bleeding Disorder: The Forgotten Patient?
6/23/2011

Today patients with haemophilia broke a taboo and spoke out in aid of women with bleeding disorders who are often the "forgotten patients" and must struggle to find the care they desperately need. In a European Haemophilia Consortium Round Table on the issue, Health care providers and politicians heard the plight of these patients and formed strategies on what can be done to help...

The Goal Of New Research Area: Slowing The Spread Of Drug-Resistant Diseases
6/23/2011

In the war between drugs and drug-resistant diseases, is the current strategy for medicating patients giving many drug-resistant diseases a big competitive advantage?, asks a research paper that will be published in the Proceedings of the National Academy of Sciences...

Making Cancer Cells More Vulnerable To Chemotherapy
6/23/2011

Imagine dropping dish soap into a sink full of greasy water. What happens? As soon as the soap hits the water, the grease recoils - and retreats to the edges of the sink...

Earlier Diagnosis Of Liver Cancer
6/23/2011

Hepatocellular carcinoma is the most common cancer to strike the liver. More than 500,000 people worldwide, concentrated in sub-Saharan Africa and Southeast Asia, are diagnosed with it yearly. Most of those afflicted die within six months. A big obstacle to treatment of liver cancer is the lack of early diagnosis...

Young Asian Women At Greater Risk For Breast Cancer According To Scientists At Cancer Prevention Institute Of California
6/23/2011

In a study that shatters accepted notions of breast cancer risk, scientists from the Cancer Prevention Institute of California (CPIC), just announced that some young Asian and Pacific Islander women are at a much higher risk than previously thought...

Genetic Finding Offers Hope For Orphan Disease: New Drugs Should Work For Rare Blood Disorder
6/23/2011

New research conducted at UNC Lineberger Comprehensive Cancer Center, offers hope for people with a rare disorder called Chuvash polycythemia. Polycythemia is a disease characterized by excessive production of red blood cells. Symptoms include an enlarged spleen, blood clots, an increased risk of stroke, and in some cases the disease is a precursor to acute leukemia...